Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study-Reference-Cited by-同舟云学术

Changes in alkaline phosphatase levels in patients with prostate cancer receiving degarelix or leuprolide: results from a 12-month, comparative, phase III study

Published:2009-11-13 Issue:2 Volume:106 Page:182-187
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:

Author:

Schröder Fritz H.,Tombal Bertrand,Miller Kurt,Boccon-Gibod Laurent,Shore Neal D.,Crawford E. David,Moul Judd,Olesen Tine Kold,Persson Bo-Eric

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2009.08981.x/fullpdf

Reference30 articles.

1. Prostate cancer metastases to bone: observational study for the evaluation of clinical presentation, course and treatment patterns. Presentation of the METAURO protocol and of patient baseline features;Conti;Arch Ital Urol Androl,2008

2. Prostate cancer, serum parathyroid hormone, and the progression of skeletal metastases;Schwartz;Cancer Epidemiol Biomarkers Prev,2008

3. Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: diagnostic and prognostic implications;Jung;Int J Cancer,2004

4. Prostate carcinoma staging. Clinical utility of bone alkaline phosphatase in addition to prostate specific antigen;Morote;Cancer,1996

5. Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase;Wymenga;BJU Int,2001

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen Deprivation Therapy and Newly Developed Neovascular Age-Related Macular Degeneration Risk in Patients with Prostate Cancer;Journal of Clinical Medicine;2024-05-18

2. An overview of hormonal directed pharmacotherapy for the treatment of prostate cancer;Expert Opinion on Pharmacotherapy;2023-08-07

3. Cost-effectiveness analysis of androgen deprivation therapy with relugolix for the treatment of advanced prostate cancer;Journal of the American Pharmacists Association;2022-12

4. Recurrent Disseminated Intravascular Coagulation in Metastatic Castration-Resistant Prostate Cancer: A Case Report;Diagnostics;2022-09-28

5. The Skeletal Effects of Gonadotropin-Releasing Hormone Antagonists: A Concise Review;Endocrine, Metabolic & Immune Disorders - Drug Targets;2021-10